TrialBritish journal of cancer1997

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.

G J Veldhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.